Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Antisoma temporarily halts Theragyn phase III enrollment

May 29, 2000

News from ASCO: Medarex's MDX-210 may be useful in breast cancer and ovarian cancer

May 26, 2000

Vaccination with ras peptides as therapeutic strategy in pancreatic cancer

May 26, 2000

Cell Genesys reports encouraging preclinical data for leukemia vaccine

May 25, 2000

DSMB recommends continuation of Theratope phase III trial

May 22, 2000

Major approval obtained for Mylotarg, the first antibody-targeted chemotherapy product

May 19, 2000

Mechanism of action of OvaRex clarified

May 16, 2000

DSRB review supports continuation of Allovectin-7 trials

May 16, 2000

Therion's Prostvac vaccine shows promise in phase I prostate cancer study

May 15, 2000

Important drug warning issued for Herceptin

May 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...